Standout Papers

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, p... 2019 2026 2021 2023 232
  1. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial (2019)
    Lieven Lagae, Joseph Sullivan et al. The Lancet

Immediate Impact

1 by Nobel laureates 12 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

STING orchestrates the neuronal inflammatory stress response in multiple sclerosis
2024 Standout
New epilepsy therapies in development
2024 Standout
14 intermediate papers

Works of Dinesh Talwar being referenced

Fenfluramine HCl (Fintepla®) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study
2020
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
2019 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Dinesh Talwar 946 512 296 489 33 1.7k
David E. Mandelbaum 669 376 312 393 38 1.5k
Laura Licchetta 724 239 323 377 86 1.5k
Stefan Beyenburg 720 450 246 380 55 1.6k
E Peeters 628 546 200 193 46 1.7k
Ignacio Valencia 944 649 309 270 84 1.7k
Ingrid Bjerre 538 689 128 632 43 2.1k
Eleanor Hancock 1475 1054 224 304 28 2.0k
Giovanni Lanzi 529 348 370 235 62 1.9k
Donald Younkin 313 446 235 435 38 2.0k
Hadassa Goldberg‐Stern 780 382 247 424 51 1.5k

All Works

Loading papers...

Rankless by CCL
2026